Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06101758
What this trial is testing

Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study

Who this might be right for
Liver CirrhosisNon-Alcoholic Fatty Liver DiseaseHepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 125
Testing effectiveness (Phase 2)Ended earlyNCT04048876
What this trial is testing

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Cirrhosis
Celgene 56
Not applicableEnrolling By InvitationNCT04066608
What this trial is testing

Prevalence of Advanced Fibrosis in Patients Living With HIV

Who this might be right for
Fatty Liver Disease
Johannes Gutenberg University Mainz 300
Not applicableStudy completedNCT07663682
What this trial is testing

Correlation Between Serum Nociceptin and Sympathetic Nerve Activity in Diabetic Patients With MAFLD

Who this might be right for
Diabetes Mellitus, Type 2Metabolic Associated Fatty Liver Disease
Second Hospital of Shanxi Medical University 100
Testing effectiveness (Phase 2)Study completedNCT04321031
What this trial is testing

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis With Liver Fibrosis
Pfizer 256
Not applicableUnknownNCT04369521
What this trial is testing

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
National Nutrition and Food Technology Institute 50
Not applicableUnknownNCT05654129
What this trial is testing

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital, Toulouse 182
Not applicableActive Not RecruitingNCT04595474
What this trial is testing

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, Liver+2 more
Joslin Diabetes Center 533
Not applicableStudy completedNCT04774302
What this trial is testing

Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

Who this might be right for
NAFLD
Clinique Pasteur 292
Early research (Phase 1)Ended earlyNCT05604287
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects

Who this might be right for
Healthy Participants
IlDong Pharmaceutical Co Ltd 67
Not applicableUnknownNCT05708560
What this trial is testing

Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study

Who this might be right for
Hepatitis B, Chronic
Erasmus Medical Center 800
Testing effectiveness (Phase 2)Study completedNCT03486899
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Who this might be right for
Liver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis
Bristol-Myers Squibb 197
Not applicableWithdrawnNCT02658786
What this trial is testing

Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease

Who this might be right for
HBVNAFLDHCV
Institute of Liver and Biliary Sciences, India
Not applicableStudy completedNCT01492283
What this trial is testing

Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

Who this might be right for
Non Alcoholic Fatty Liver DiseaseType 2 DiabetesLiver Cirrhosis
University Hospital, Gentofte, Copenhagen 48
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Not applicableUnknownNCT03525769
What this trial is testing

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University 10,000
Not applicableStudy completedNCT02031913
What this trial is testing

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

Who this might be right for
Chronic Hepatitis BHepatic FibrosisFatty Liver
Seoul National University Boramae Hospital 500
Not applicableWithdrawnNCT01987310
What this trial is testing

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sheba Medical Center
Not applicableLooking for participantsNCT05766449
What this trial is testing

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

Who this might be right for
Chronic Hepatitis bNon-alcoholic Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Not applicableEnded earlyNCT03479125
What this trial is testing

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Who this might be right for
Liver DiseasesLiver FibrosisLiver Cirrhosis+3 more
Conatus Pharmaceuticals Inc. 40
Next Page